Extended Data Table 4 Number of SAEs

From: Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial

  1. The numbers of AEs, treatment-related AEs, serious AEs (SAEs), treatment-related SAEs, and fatal SAEs are reported. Patient numbers and percentages are indicated.
Back to article page